Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
Drug-induced immune haemolytic anaemia (DIIHA) is extremely rare. We herein report a case of DIIHA due to co-amoxiclav. A 53-year-old male being treated for left-sided pyelonephritis with intravenous co-amoxiclav developed symptoms and signs of anaemia on the third day of treatment. He was found to...
Saved in:
Main Authors: | H. G. C. S. Karunathilaka, D. P. Chandrasiri, P. Ranasinghe, V. Ratnamalala, A. H. N. Fernando |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/9841097 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Pentoxifylline and Vitamin E on Ribavirin-Induced Haemolytic Anaemia in Chronic Hepatitis C Patients: An Egyptian Survey
by: M. Assem, et al.
Published: (2011-01-01) -
Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil
by: Sarah Green, et al.
Published: (2016-01-01) -
Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review
by: P. Maurice, et al.
Published: (2025-02-01) -
Musculoskeletal Manifestations of Sickle Cell Anaemia: A Pictorial Review
by: A. Ganguly, et al.
Published: (2011-01-01) -
Sarcomatoid Renal Cell Carcinoma in an Adolescent with Sickle Cell Anaemia
by: H. R. Ahmad, et al.
Published: (2017-01-01)